Daniel Lachant is a Respiratory physician affiliated with University of Rochester Medical Center. OpenAlex indexes 94 publications with 353 citations (h-index 11); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
601 Elmwood Ave
Box Med
Rochester, NY 146420001
Telephone
585-275-2874Registry record last updated 6 Jul 2023.
Clinical trials
- Home Rehabilitation After Acute Pulmonary Embolism
Sponsor: University of Rochester
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Merck Sharp & Dohme LLCProgram year202510 payments
- Actelion Pharmaceuticals US, Inc.Program year20256 payments
- United Therapeutics CorporationProgram year202520 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
49.1%Endothelin Receptor Antagonist28.7%Ambrisentan98%Opsumit3%Part D<11 patientsLoop diuretic5.5%Torsemide100%Part D≥38 patients+ 4 more classes in this area
Genitourinary & hormones
36.1%Phosphodiesterase 5 Inhibitor36.1%Tadalafil100%Part D≥84 patientsBlood & clotting
9.8%Prostacycline Vasodilator9.8%Tyvaso Dpi54%Orenitram Er46%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2024–2026 per NIH RePORTER. The latest:
- Electronically Delivered Home Rehabilitation to Improve Symptoms and Activity After Pulmonary Embolism
University of Rochester
FY2026$188,376K23HL171867 - Electronically Delivered Home Rehabilitation to Improve Symptoms and Activity After Pulmonary Embolism
University of Rochester
FY2025$187,296K23HL171867 - Electronically Delivered Home Rehabilitation to Improve Symptoms and Activity After Pulmonary Embolism
University of Rochester
FY2024$187,296K23HL171867
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- International Society for Heart and Lung Transplantation (ISHLT) Consensus Statement on Risk Stratification in Pulmonary Arterial Hypertension
The Journal of Heart and Lung Transplantation
2025 - Authors’ Perspective on the International Society for Heart and Lung Transplantation Consensus Statement on Risk Stratification in Pulmonary Arterial Hypertension
The Journal of Heart and Lung Transplantation
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Ann Falsey, MD
University of Rochester Medical Center
Louis Constine, MD
University of Rochester Medical Center
Supriya Mohile, MD
University of Rochester Medical Center
Edward Messing, MD
University of Rochester Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”